Bio-Techne

377 articles about Bio-Techne

• Bio-Techne to Present at the Stephens Annual Investment Conference

  11/10/2022

  Bio-Techne Corporation announced that Jim Hippel, Executive Vice President and Chief Financial Officer, will present at the Stephens Annual Investment Conference on Thursday, November 17, 2022, at 10:00 a.m. CST.

• BIO-TECHNE TO PRESENT AT THE STIFEL 2022 HEALTHCARE CONFERENCE

  11/8/2022

  Bio-Techne Corporation (NASDAQ: TECH) today announced that Jim Hippel , Executive Vice President and Chief Financial Officer, will present at the Stifel 2022 Healthcare Conference on Tuesday, November 15, 2022 , at 2:25 p.m. EST.

• Bio-Techne to Present at the Credit Suisse 31st Annual Healthcare Conference

  11/3/2022

  Bio-Techne Corporation announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Credit Suisse 31st Annual Healthcare Conference on Wednesday, November 9, 2022, at 8:35 a.m. PST.

• Bio-Techne Releases First Quarter Fiscal 2023 Results

  11/1/2022

  Bio-Techne Corporation reported its financial results for the first quarter ended September 30, 2022.

• Bio-Techne Declares Cash Dividend and Stock Dividend payable November 28, 2022

  11/1/2022

  Bio-Techne Corporation announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended September 30, 2022.

• Asuragen to Showcase Innovative Diagnostic Lab Solutions at AMP 2022 Conference

  10/31/2022

  Bio-Techne Corporation (NASDAQ: TECH) today announced that Asuragen, a Bio-Techne brand, will present its diagnostic lab solutions at the upcoming annual meeting of the Association for Molecular Pathology (AMP), taking place November 1-5 in Phoenix, Ariz.

• Bio-Techne Introduces New Simple Plex AAV Viral Titer Assays

  10/11/2022

  Bio-Techne Corporation and PROGEN announced the release of three new Simple Plex™ Adeno-Associated Virus viral titer assays for intact AAV capsid quantification.

• BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS

  10/10/2022

  Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday, November 1, 2022 , at 8:00 a.m. CDT to review first quarter 2023 financial results.

• BIO-TECHNE COMMERCIALIZES AUTOMATED MULTI-OMIC RNASCOPE ASSAYS FOR SPATIAL VISUALIZATION OF RNA AND PROTEIN BIOMARKERS IN FFPE TISSUES

  10/6/2022

  Bio-Techne Corporation (NASDAQ: TECH) today announced the expansion of the Advanced Cell Diagnostics (ACD)-branded RNAscope™ in situ hybridization (ISH) portfolio with the release of new automated co-detection assays specifically designed for the Roche DISCOVERY ULTRA Platform, enabling simultaneous detection of RNA and protein on the same tissue section.

• ScaleReady Introduces the Cue® Cell Processing System From Fresenius Kabi

  10/3/2022

  ScaleReady Introduces the Cue ® Cell Processing System From Fresenius Kabi.

• Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments

  9/26/2022

  Bio-Techne Corporation today announced that it has taken legal action in the United Kingdom to halt the infringement of its patented RNAscope® ISH technology by Molecular Instruments, Inc.

• BIO-TECHNE ISSUES 2022 CORPORATE SUSTAINABILITY REPORT

  9/19/2022

  Bio-Techne Corporation (NASDAQ: TECH) today issued its 2022 Corporate Sustainability Report (CSR).

• Bio-Techne Presents Initial Data on Sjögren's Syndrome Monitoring Assay

  9/8/2022

  Bio-Techne Corporation announced that Exosome Diagnostics, a Bio-Techne brand, will present initial data on their novel non-invasive saliva profiling assay for Sjögren's Syndrome diagnosis and monitoring at the 15th International Symposium on Sjögren's Syndrome in Rome, Italy on Friday Sept 9.

• Bio-Techne to Seek Approval to Implement Four-for-One Stock Split - Sep 01, 2022

  9/1/2022

  Bio-Techne Corporation announced its plan to request shareholder approval during its upcoming 2022 Annual Meeting of Shareholders for an increase in the total number of authorized shares of common stock through an amendment to the Company's Articles of Incorporation to implement a four-for-one forward stock split in the form of a stock dividend.

• BIO-TECHNE TO PRESENT AT THE MORGAN STANLEY 20th ANNUAL GLOBAL HEALTHCARE CONFERENCE

  8/30/2022

  Bio-Techne Corporation (NASDAQ: TECH) today announced that Jim Hippel, Executive Vice President and Chief Financial Officer, will present at the Morgan Stanley 20th Annual Global Healthcare Conference on Tuesday, September 13, 2022, at 1:30 p.m. EST.

• BIO-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE

  8/29/2022

  Bio-Techne Corporation (NASDAQ: TECH) today announced that Jim Hippel , Executive Vice President and Chief Financial Officer, will present at the 2022 Wells Fargo Healthcare Conference on Wednesday, September 7, 2022 , at 9:10 a.m. EST.

• Maurice icIEF Established as a Green Method for Characterization of AAV Identity and Stability

  8/25/2022

  Bio-Techne Corporation announced the publication of a study in the Green Analytical Chemistry journal, titled Establishment of a Platform Imaged Capillary Isoelectric Focusing Characterization Method for Adeno-Associated Virus Capsid Proteins.

• BIO-TECHNE INCLUDED IN THE FORBES BEST-IN-STATE EMPLOYERS 2022 LIST

  8/24/2022

  Bio-Techne Corporation (NASDAQ: TECH) today announced that it has been included in the Forbes list of Best-in-State Employers 2022.

• BIO-TECHNE ANNOUNCES RELEASE OF QUANTIST LUMINEX® DATA ANALYSIS SOFTWARE

  8/18/2022

  Bio-Techne Corporation (NASDAQ: TECH) today announced that R&D Systems®, a Bio-Techne brand, has released its new Quantist Luminex® data analysis software.

• BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS

  7/14/2022

  Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday, August 4, 2022 , at 8:00 a.m. CDT to review fourth quarter 2022 financial results.